2024第二届中澳肿瘤囊泡及肿瘤标志物新进展学术研讨会 (浙江宁波)
The Second China-Australia Symposium on Tumor Extracellular Vesicles (CASTEV) (Ningbo, Zhejiang)
恶性肿瘤诊治的关键是早期发现,监测转移,理解肿瘤发生发展机制,研发新的肿瘤药物及新的治疗方法。其目的是延长患者的生存期,提高患者的生活质量,改善患者的预后。囊泡在肿瘤的发生,发展及转移过程中发挥着非常重要的作用。肿瘤囊泡的成份比较稳定,可用于肿瘤的早期诊断,监测肿瘤复发及进展,观察疗效。此外,肿瘤囊泡也可做为载体用与靶向治疗。囊泡的研究正在成为肿瘤研究的一个热点。有关囊泡研究的文章像雨后春荀般的层出不穷。2024第二届中澳肿瘤囊泡及肿瘤标志物新进展疗进展国际学术研讨会将邀请有多年从事肿瘤囊泡,液体活检,肿瘤治疗靶向治疗及免疫治疗,肿瘤微环境及肿瘤转移研究取得了突出成就的国际,国内专家讨论肿瘤研究的前沿问题,演讲嘉宾将通过演讲和答疑互动的方式,以期达到交流及提高科研水平的目的。
The key to the diagnosis and treatment of cancers is early detection, monitoring of metastasis, understanding the mechanism of cancer occurrence and development, and developing new cancer drugs and new treatment methods. The purpose is to prolong the patient's survival, improve the patient's quality of life, and improve the patient's prognosis. Extracellular vesicles (EVs) play a very important role in the occurrence, development, and metastasis of cancers. The components of cancer-derived vehicles are relatively stable and can be used for early cancer diagnosis, monitoring cancer recurrence and progression, and observing therapeutic effects. In addition, cancer-derived vesicles can also be used as carriers and targeted therapies. The study of EVs is becoming a hot spot in cancer research. Articles on EV research are emerging like spring after a rain. The 2024 Second China-Australia International Academic Symposium on New Treatment Progress in Tumor Vesicles and Tumor Markers will invite experts who have been engaged in cancer vesicles, liquid biopsy, cancer treatment targeted therapy and immunotherapy, tumor microenvironment and cancer metastasis for many years. International and domestic experts with outstanding achievements will discuss cutting-edge issues in cancer research. Guest speakers will communicate and improve the level of scientific research through speeches and Q&A interactions.
承办单位:宁波大学附属第一医院
地点:富邦大酒店 3 楼天祥厅
日期:2024.3.30 (星期六)